Chemical Formula: C16H13ClN2O

Chemical Formula C16H13ClN2O

Found 19 metabolite its formula value is C16H13ClN2O

Diazepam

7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one

C16H13ClN2O (284.0716358)


Diazepam is a benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of gamma-aminobutyric acid activity. It is used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome. (From Martindale, The Extra Pharmacopoeia, 30th ed, p589). Diazepam, first marketed as Valium by Hoffmann-La Roche, is a benzodiazepine derivative drug. It is commonly used for treating anxiety, insomnia, seizures including status epilepticus, muscle spasms (such as in cases of tetanus), restless legs syndrome, alcohol withdrawal, benzodiazepine withdrawal and Ménières disease. Diazepam is found in potato and common wheat. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D005765 - Gastrointestinal Agents > D000932 - Antiemetics CONFIDENCE standard compound; EAWAG_UCHEM_ID 2626 CONFIDENCE standard compound; INTERNAL_ID 4084 CONFIDENCE standard compound; INTERNAL_ID 1608 CONFIDENCE standard compound; INTERNAL_ID 8560

   

Mazindol

5-(4-chlorophenyl)-2H,3H,5H-imidazo[2,1-a]isoindol-5-ol

C16H13ClN2O (284.0716358)


Mazindol is only found in individuals that have used or taken this drug. It is a tricyclic anorexigenic agent unrelated to and less toxic than amphetamine, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter. [PubChem]Although the mechanism of action of the sympathomimetics in the treatment of obesity is not fully known, these medications have pharmacological effects similar to those of amphetamines. Unlike other sympathomimetic appetite suppressants such as phentermine, mazindol is thought to inhibit the reuptake of norepinephrine rather than to cause its release. A - Alimentary tract and metabolism > A08 - Antiobesity preparations, excl. diet products > A08A - Antiobesity preparations, excl. diet products > A08AA - Centrally acting antiobesity products D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

4(3H)-Quinazolinone, 3-(4-chloro-2-methylphenyl)-2-methyl-

3-(4-chloro-2-methylphenyl)-2-methyl-3,4-dihydroquinazolin-4-one

C16H13ClN2O (284.0716358)


   

4(3H)-Quinazolinone, 3-(3-chloro-2-methylphenyl)-2-methyl-

3-(3-chloro-2-methylphenyl)-2-methyl-3,4-dihydroquinazolin-4-one

C16H13ClN2O (284.0716358)


   

4(3H)-Quinazolinone, 3-(5-chloro-2-methylphenyl)-2-methyl-

3-(5-chloro-2-methylphenyl)-2-methyl-3,4-dihydroquinazolin-4-one

C16H13ClN2O (284.0716358)


   

diazepam

diazepam

C16H13ClN2O (284.0716358)


A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D005765 - Gastrointestinal Agents > D000932 - Antiemetics

   

mazindol

mazindol

C16H13ClN2O (284.0716358)


A - Alimentary tract and metabolism > A08 - Antiobesity preparations, excl. diet products > A08A - Antiobesity preparations, excl. diet products > A08AA - Centrally acting antiobesity products D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

4-chloro-3-methyl-6-(2-phenyl-1H-pyrazol-3-ylidene)cyclohexa-2,4-dien-1-one

4-chloro-3-methyl-6-(2-phenyl-1H-pyrazol-3-ylidene)cyclohexa-2,4-dien-1-one

C16H13ClN2O (284.0716358)


   

4-CHLORO-2-(4-METHOXY-PHENYL)-5-METHYL-QUINAZOLINE

4-CHLORO-2-(4-METHOXY-PHENYL)-5-METHYL-QUINAZOLINE

C16H13ClN2O (284.0716358)


   

4-CHLORO-2-(4-METHOXY-PHENYL)-6-METHYL-QUINAZOLINE

4-CHLORO-2-(4-METHOXY-PHENYL)-6-METHYL-QUINAZOLINE

C16H13ClN2O (284.0716358)


   

3-(4-chlorophenyl)-1-phenyl-1H-pyrazole-4-methanol

3-(4-chlorophenyl)-1-phenyl-1H-pyrazole-4-methanol

C16H13ClN2O (284.0716358)


   

7-chloro-2-methoxy-5-phenyl-3H-1,4-benzodiazepine

7-chloro-2-methoxy-5-phenyl-3H-1,4-benzodiazepine

C16H13ClN2O (284.0716358)


   

7-chloro-3-methyl-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one

7-chloro-3-methyl-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one

C16H13ClN2O (284.0716358)


   

4-[(4-chloroanilino)methyl]-1H-quinolin-2-one

4-[(4-chloroanilino)methyl]-1H-quinolin-2-one

C16H13ClN2O (284.0716358)


   

9b-(4-chlorophenyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5-one

9b-(4-chlorophenyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5-one

C16H13ClN2O (284.0716358)


   

4(3H)-Quinazolinone, 3-(4-chloro-2-methylphenyl)-2-methyl-

4(3H)-Quinazolinone, 3-(4-chloro-2-methylphenyl)-2-methyl-

C16H13ClN2O (284.0716358)


   

5-[(2-Chloroanilino)methyl]quinolin-8-ol

5-[(2-Chloroanilino)methyl]quinolin-8-ol

C16H13ClN2O (284.0716358)


   

2-[(3-Chlorophenyl)methoxy]-3-methylquinoxaline

2-[(3-Chlorophenyl)methoxy]-3-methylquinoxaline

C16H13ClN2O (284.0716358)


   

7-chloro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-3-one

7-chloro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-3-one

C16H13ClN2O (284.0716358)